Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125495181 | 12549518 | 1 | I | 20160628 | 20160630 | 20160712 | 20160712 | PER | US-BAYER-2016-130473 | BAYER | 65.00 | YR | E | F | Y | 81.63000 | KG | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125495181 | 12549518 | 1 | PS | CLARITIN REDITABS | LORATADINE | 1 | Oral | 1 DF, QD | Y | LEFBT100 | 20704 | 1 | DF | ORODISPERSIBLE TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125495181 | 12549518 | 1 | Multiple chemical sensitivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125495181 | 12549518 | Eye discharge | |
| 125495181 | 12549518 | Eyelid oedema | |
| 125495181 | 12549518 | Grip strength decreased | |
| 125495181 | 12549518 | Joint swelling | |
| 125495181 | 12549518 | Limb discomfort | |
| 125495181 | 12549518 | Lip swelling | |
| 125495181 | 12549518 | Nasal oedema | |
| 125495181 | 12549518 | Paraesthesia | |
| 125495181 | 12549518 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125495181 | 12549518 | 1 | 20160628 | 20160629 | 0 |